{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T13:19:06Z","timestamp":1780924746560,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.medmal.2005.11.009","type":"journal-article","created":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T14:55:18Z","timestamp":1141224918000},"page":"157-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lymphomes non hodgkiniens et\u00a0hodgkiniens et\u00a0infection VIH\u00a0: fr\u00e9quence, pronostic et\u00a0reconstitution immune sous\u00a0trith\u00e9rapie antir\u00e9trovirale\u00a0; CHU de\u00a0Clermont-Ferrand, 1991\u20132003"],"prefix":"10.1016","volume":"36","author":[{"given":"C.","family":"Jacomet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Lesens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Villemagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Darcha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Tournilhac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Henquell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Cormerais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Gourdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Peigue-Lafeuille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Travade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Beytout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Laurichesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2005.11.009_bib1","first-page":"S11","article-title":"Effect of antiretroviral therapy on recent trends of selected cancers among HIV-infected persons","volume":"21","author":"Jones","year":"1999","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"10.1016\/j.medmal.2005.11.009_bib2","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1182\/blood.V96.8.2730","article-title":"Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy","volume":"96","author":"Matthews","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.medmal.2005.11.009_bib3","first-page":"390","article-title":"The epidemiology of acquired immunodeficiency syndrome malignancies","volume":"27","author":"Goedert","year":"2000","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.medmal.2005.11.009_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00005792-200303000-00001","article-title":"The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era","volume":"82","author":"Vilchez","year":"2003","journal-title":"Medicine"},{"key":"10.1016\/j.medmal.2005.11.009_bib5","first-page":"478","article-title":"Systemic non lymphoma in HIV-infected patients with effective suppression of HIV replication: Persistent occurrence but improved survival","volume":"30","author":"Gerard","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.medmal.2005.11.009_bib6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00002030-200301030-00011","article-title":"Improved survival in HIV-related Hodgkin's lymphoma since the introduction of highly active antiretroviral therapy","volume":"17","author":"Gerard","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.medmal.2005.11.009_bib7","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/(SICI)1097-0142(20000401)88:7<1696::AID-CNCR25>3.0.CO;2-L","article-title":"Pronostic factors after non_Hodgkin lymphoma in patients infected with the immunodeficiency virus. Aquitaine cohort, France 1986-1997. Groupe d'epid\u00e9miologie clinique du sida en Aquitaine (GESCA)","volume":"88","author":"Thiessard","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.medmal.2005.11.009_bib8","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/00002030-200108170-00005","article-title":"Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy","volume":"15","author":"Antinori","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.medmal.2005.11.009_bib9","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood.V98.8.2339","article-title":"Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy","volume":"98","author":"Besson","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.medmal.2005.11.009_bib10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3816\/CLM.2003.n.016","article-title":"Acquired immunodeficiency syndrome-related lymphoma in the era of highly active antiretroviral therapy","volume":"4","author":"Thirlwell","year":"2003","journal-title":"Clin. Lymphoma"},{"key":"10.1016\/j.medmal.2005.11.009_bib11","first-page":"704","article-title":"The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapy","volume":"90","author":"Navarro","year":"2005","journal-title":"Haematologica"},{"issue":"31","key":"10.1016\/j.medmal.2005.11.009_bib12","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00126334-200212150-00012","article-title":"Prevalence of hepatitis C virus infection and risk for hepatocellular carcinoma and non-Hodgkin lymphoma in AIDS","volume":"15","author":"Engels","year":"2002","journal-title":"J. Aquir. Immune Defic. Syndrom"},{"key":"10.1016\/j.medmal.2005.11.009_bib13","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1182\/blood-2002-10-3230","article-title":"Hepatitis C virus and B-cell non Hodgkin lymphomas: an Italian multicentrecase-control study","volume":"102","author":"Mele","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.medmal.2005.11.009_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ijc.20988","article-title":"Hepatitis C infection is not associated with systemic HIV-associated non Hodgkin's lymphoma: A cohort study","volume":"116","author":"Waters","year":"2005","journal-title":"Int. J. Cancer."},{"key":"10.1016\/j.medmal.2005.11.009_bib15","first-page":"523","article-title":"Lymphoma genesis in the context of HIV infection","volume":"154","author":"Besson","year":"2003","journal-title":"Ann. Med. Interne (Paris)"},{"key":"10.1016\/j.medmal.2005.11.009_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/10428190009053542","article-title":"Intensive chemotherapy (LNHVIH-91 regimen) and G-CSF for HIV associated non-Hodgkin\u2019s lymphoma","volume":"39","author":"Oksenhendler","year":"2000","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.medmal.2005.11.009_bib17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1586\/14737140.4.3.401","article-title":"Current treatment strategies for patients with Hodgkin's lymphoma and HIV infection","volume":"4","author":"Hartmann","year":"2004","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.medmal.2005.11.009_bib18","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/cncr.20354","article-title":"Malignancy related causes of death in Human Immunodeficiency Virus-infected patients in the era of highly active antiretroviral therapy","volume":"101","author":"Bonnet","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.medmal.2005.11.009_bib19","first-page":"4430","article-title":"AIDS-Related Burkitt\u2019s Lymphoma vs Diffuse Large Cell Lymphoma in the Pre-Highly Active Antiretroviral Therapy (HAART) and HAART Eras: Significant differences in survival with standard chemotherapy","volume":"23","author":"Lim","year":"2005","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.medmal.2005.11.009_bib20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/1042819031000060537","article-title":"Successful treatment of aggressive HIV-associated non-Hodgkin\u2019s lymphoma with combination chemotherapy, biotherapy with rituximab and HAART: presentation of a therapeutic option","volume":"44","author":"Klepfish","year":"2003","journal-title":"Leuk lymphoma"},{"issue":"5","key":"10.1016\/j.medmal.2005.11.009_bib21","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1182\/blood-2004-12-4729","article-title":"HIV-associated lymphoma: promising new results, but with toxicity","volume":"105","author":"Straus","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.medmal.2005.11.009_bib22","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1182\/blood-2005-04-1437","article-title":"Rituximab does not improve clinical outcome in a randomized phase III trial of CHOP with or without rituximab in patients with HIV-associated non Hodgkin's lymphoma: AIDS-malignancies consortium trial 010","volume":"106","author":"Kaplan","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.medmal.2005.11.009_bib23","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(04)16930-4","article-title":"HIV\/HCV co-infection, HAART, and liver related mortality","volume":"364","author":"Sabin","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2005.11.009_bib24","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/S0264-410X(99)00089-4","article-title":"Immunogenicity of three Haemophilus influenzae type b protein conjugate vaccines in HIV seropositive adults and analysis of predictors of vaccine response","volume":"17","author":"Dockrell","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.medmal.2005.11.009_bib25","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00002030-199807000-00011","article-title":"Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease","volume":"12","author":"Picketty","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.medmal.2005.11.009_bib26","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1086\/383034","article-title":"Immune reconstitution in HIV-infected patients","volume":"38","author":"Hirsch","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2005.11.009_bib27","unstructured":"Laporte R, Gerard Y, Ajana F, Yasdanpanah Y. Denis, G Baclet et al. Burkitt leukemia outcome following IL2 infusion in an HIV-infected patient. XV International AIDS Conference. Bangkok 2004. N\u00b0 PeB5694."}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X05003471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X05003471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:01:16Z","timestamp":1759971676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X05003471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0399077X05003471"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2005.11.009","relation":{},"ISSN":["0399-077X"],"issn-type":[{"value":"0399-077X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphomes non hodgkiniens et\u00a0hodgkiniens et\u00a0infection VIH\u00a0: fr\u00e9quence, pronostic et\u00a0reconstitution immune sous\u00a0trith\u00e9rapie antir\u00e9trovirale\u00a0; CHU de\u00a0Clermont-Ferrand, 1991\u20132003","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2005.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}